Enzo Biochem (ENZ) Reports In-Line Q4 EPS
Tweet
Share
E-mailGet Alerts ENZ Hot Sheet
Join SI Premium – FREE
Enzo Biochem (NYSE: ENZ) reported Q4 EPS of $, in-line with the analyst estimate of $0.00. Revenue for the quarter came in at $32.6 million, versus $0 reported last year.
For earnings history and earnings-related data on Enzo Biochem (ENZ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Allison Transmission (ALSN) Tops Q2 EPS by 33c; offers guidance
- Hillman Solutions (HLMN) Reports In-Line Q2 EPS; offers guidance
- HealthStream (HSTM) Tops Q2 EPS by 6c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
